MXC.L Stock - MGC Pharmaceuticals Limited
Unlock GoAI Insights for MXC.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $3.39M | $4.73M | $3.00M | $2.08M | $656,237 |
| Gross Profit | $1.29M | $562,868 | $1.10M | $174,664 | $299,595 |
| Gross Margin | 38.0% | 11.9% | 36.7% | 8.4% | 45.7% |
| Operating Income | $-15,234,000 | $-15,499,000 | $-11,939,000 | $-11,286,000 | $-8,712,000 |
| Net Income | $-20,824,000 | $-20,347,000 | $-15,870,000 | $-18,763,000 | $-11,009,000 |
| Net Margin | -614.6% | -430.0% | -529.7% | -902.5% | -1677.6% |
| EPS | $-7.10 | $-7.90 | $-8.30 | $-14.00 | $-9.11 |
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in Australia, Israel, and Slovenia. The company's principal product candidates include CimetrA, which is in phase III clinical trial for early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for symptomatic relief of Dementia. It has research and development agreement with Royal Melbourne Institute of Technology and the University of Notre Dame; and collaboration agreement with the Slovenian National Institute of Biology and Neurosurgery Department at the University Medical Centre. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is headquartered in West Perth, Australia.
Visit WebsiteEarnings History & Surprises
MXC.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2024 | Feb 28, 2024 | — | $-16.39 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-1.58 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-2.34 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-2.57 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-1.77 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-2.47 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-2.04 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-2.80 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-4.94 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-2.61 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-2.54 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.61 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-3.71 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-3.04 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-1.88 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-2.15 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-3.40 | — | — |
Q2 2015 | Jun 30, 2015 | — | $-4.20 | — | — |
Q4 2014 | Dec 31, 2014 | — | $-2.35 | — | — |
Q2 2014 | Jun 30, 2014 | — | $-14.59 | — | — |
Latest News
Frequently Asked Questions about MXC.L
What is MXC.L's current stock price?
What is the analyst price target for MXC.L?
What sector is MGC Pharmaceuticals Limited in?
What is MXC.L's market cap?
Does MXC.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MXC.L for comparison